Peter Altman - Apr 14, 2022 Form 4 Insider Report for BioCardia, Inc. (BCDA)

Signature
/s/ David McClung, by power of attorney
Stock symbol
BCDA
Transactions as of
Apr 14, 2022
Transactions value $
$18,700
Form type
4
Date filed
4/18/2022, 09:17 PM
Previous filing
Apr 14, 2023
Next filing
May 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCDA Common Stock Award $0 +76.7K +32.25% $0.00 315K Apr 14, 2022 Direct F1
transaction BCDA Common Stock Purchase $18.7K +13.5K +4.29% $1.39 328K Apr 18, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCDA Stock Option (right to buy) Award $0 +141K $0.00 141K Apr 14, 2022 Common Stock 141K $1.49 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. 100% of the RSUs vested on April 14, 2022.
F2 This transaction was executed in multiple trades ranging from $1.37 to $1.40 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price.
F3 The option vests and becomes exercisable as to 1/48th of the shares on May 14, 2022, and each month thereafter, subject to the Reporting Person continuing as a service provider through such date.